Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 110

1.

Research and standardization in Alzheimer's trials: reaching international consensus.

Carrillo MC, Rowe CC, Szoeke C, Masters CL, Ames D, O'Meara T, Macaulay SL, Milner A, Ellis KA, Maruff P, Rainey-Smith SR, Martins RN, Bain LJ, Head RJ; NIA/Alzheimer Association and International Working Group.

Alzheimers Dement. 2013 Mar;9(2):160-8. doi: 10.1016/j.jalz.2012.10.006. Epub 2012 Dec 23.

PMID:
23266004
[PubMed - indexed for MEDLINE]
2.

Core candidate neurochemical and imaging biomarkers of Alzheimer's disease.

Hampel H, Bürger K, Teipel SJ, Bokde AL, Zetterberg H, Blennow K.

Alzheimers Dement. 2008 Jan;4(1):38-48. doi: 10.1016/j.jalz.2007.08.006. Epub 2007 Dec 21. Review.

PMID:
18631949
[PubMed - indexed for MEDLINE]
3.

Advances in the prevention of Alzheimer's disease and dementia.

Solomon A, Mangialasche F, Richard E, Andrieu S, Bennett DA, Breteler M, Fratiglioni L, Hooshmand B, Khachaturian AS, Schneider LS, Skoog I, Kivipelto M.

J Intern Med. 2014 Mar;275(3):229-50. doi: 10.1111/joim.12178.

PMID:
24605807
[PubMed - indexed for MEDLINE]
4.

Harmonized diagnostic criteria for Alzheimer's disease: recommendations.

Morris JC, Blennow K, Froelich L, Nordberg A, Soininen H, Waldemar G, Wahlund LO, Dubois B.

J Intern Med. 2014 Mar;275(3):204-13. doi: 10.1111/joim.12199.

PMID:
24605805
[PubMed - indexed for MEDLINE]
5.

[The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia].

Croisile B, Auriacombe S, Etcharry-Bouyx F, Vercelletto M; National Institute on Aging (u.s.); Alzheimer Association.

Rev Neurol (Paris). 2012 Jun;168(6-7):471-82. doi: 10.1016/j.neurol.2011.11.007. Epub 2012 May 12. Review. French.

PMID:
22579080
[PubMed - indexed for MEDLINE]
6.

Development of biomarkers to chart all Alzheimer's disease stages: the royal road to cutting the therapeutic Gordian Knot.

Hampel H, Lista S, Khachaturian ZS.

Alzheimers Dement. 2012 Jul;8(4):312-36. doi: 10.1016/j.jalz.2012.05.2116. Review.

PMID:
22748938
[PubMed - indexed for MEDLINE]
7.

Biomarkers of Alzheimer disease.

Growdon JH.

Arch Neurol. 1999 Mar;56(3):281-3. Review.

PMID:
10190817
[PubMed - indexed for MEDLINE]
8.

Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: a long-range point of view beyond 2020.

Hampel H, Lista S, Teipel SJ, Garaci F, Nisticò R, Blennow K, Zetterberg H, Bertram L, Duyckaerts C, Bakardjian H, Drzezga A, Colliot O, Epelbaum S, Broich K, Lehéricy S, Brice A, Khachaturian ZS, Aisen PS, Dubois B.

Biochem Pharmacol. 2014 Apr 15;88(4):426-49. doi: 10.1016/j.bcp.2013.11.009. Epub 2013 Nov 22. Review.

PMID:
24275164
[PubMed - indexed for MEDLINE]
9.

Are biomarkers harmful to recruitment and retention in Alzheimer's disease clinical trials? An international perspective.

Hampel H, Prvulovic D.

J Nutr Health Aging. 2012 Apr;16(4):346-8.

PMID:
22499455
[PubMed - indexed for MEDLINE]
10.

Use of biomarkers and imaging to assess pathophysiology, mechanisms of action and target engagement.

Hampel H, Lista S.

J Nutr Health Aging. 2013 Jan;17(1):54-63. doi: 10.1007/s12603-013-0003-1.

PMID:
23299381
[PubMed - indexed for MEDLINE]
11.

The impact of cerebrospinal fluid biomarkers on the diagnosis of Alzheimer's disease.

Engelborghs S, Le Bastard N.

Mol Diagn Ther. 2012 Jun 1;16(3):135-41. doi: 10.2165/11634170-000000000-00000.

PMID:
22646065
[PubMed - indexed for MEDLINE]
12.

The future of Alzheimer's disease: the next 10 years.

Hampel H, Prvulovic D, Teipel S, Jessen F, Luckhaus C, Frölich L, Riepe MW, Dodel R, Leyhe T, Bertram L, Hoffmann W, Faltraco F; German Task Force on Alzheimer's Disease (GTF-AD).

Prog Neurobiol. 2011 Dec;95(4):718-28. doi: 10.1016/j.pneurobio.2011.11.008. Epub 2011 Nov 22. Review.

PMID:
22137045
[PubMed - indexed for MEDLINE]
13.

Biomarkers for Alzheimer's disease therapeutic trials.

Hampel H, Wilcock G, Andrieu S, Aisen P, Blennow K, Broich K, Carrillo M, Fox NC, Frisoni GB, Isaac M, Lovestone S, Nordberg A, Prvulovic D, Sampaio C, Scheltens P, Weiner M, Winblad B, Coley N, Vellas B; Oxford Task Force Group.

Prog Neurobiol. 2011 Dec;95(4):579-93. doi: 10.1016/j.pneurobio.2010.11.005. Epub 2010 Dec 2. Review.

PMID:
21130138
[PubMed - indexed for MEDLINE]
14.

Biomarkers for Alzheimer's disease.

Sonnen JA, Keene CD, Montine KS, Li G, Peskind ER, Zhang J, Montine TJ.

Expert Rev Neurother. 2007 Aug;7(8):1021-8. Review.

PMID:
17678497
[PubMed - indexed for MEDLINE]
15.

Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative.

Vanderstichele H, Bibl M, Engelborghs S, Le Bastard N, Lewczuk P, Molinuevo JL, Parnetti L, Perret-Liaudet A, Shaw LM, Teunissen C, Wouters D, Blennow K.

Alzheimers Dement. 2012 Jan;8(1):65-73. doi: 10.1016/j.jalz.2011.07.004. Epub 2011 Nov 2. Review.

PMID:
22047631
[PubMed - indexed for MEDLINE]
16.

Prevention trials in Alzheimer's disease: an EU-US task force report.

Vellas B, Aisen PS, Sampaio C, Carrillo M, Scheltens P, Scherrer B, Frisoni GB, Weiner M, Schneider L, Gauthier S, Gispen-de Wied CC, Hendrix S, Feldman H, Cedarbaum J, Petersen R, Siemers E, Andrieu S, Prvulovic D, Touchon J, Hampel H.

Prog Neurobiol. 2011 Dec;95(4):594-600. doi: 10.1016/j.pneurobio.2011.08.014. Epub 2011 Sep 10.

PMID:
21925234
[PubMed - indexed for MEDLINE]
17.

[A new definition for Alzheimer's disease].

Dubois B.

Bull Acad Natl Med. 2013 Jan;197(1):143-53; discussion 153-6. Review. French.

PMID:
24672986
[PubMed - indexed for MEDLINE]
18.

Study design considerations: conducting global clinical trials in early Alzheimer's disease.

Schindler RJ.

J Nutr Health Aging. 2010 Apr;14(4):312-4.

PMID:
20306004
[PubMed - indexed for MEDLINE]
19.

Biomarkers in preclinical Alzheimer's disease.

Chong MS, Lim WS, Sahadevan S.

Curr Opin Investig Drugs. 2006 Jul;7(7):600-7. Review.

PMID:
16869111
[PubMed - indexed for MEDLINE]
20.

Biomarkers for Alzheimer's disease trials--biomarkers for what? A discussion paper.

Lovestone S, Thambisetty M.

J Nutr Health Aging. 2009 Apr;13(4):334-6. No abstract available.

PMID:
19300870
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk